Both medications embody a emerging class of immunoglobulin interventions designed to inhibit the SARS-CoV-2 virus . Originally , sotrovimab, engineered by GSK , demonstrated considerable effectiveness against versions of the agent, especially during the initial phases of the pandemic . Despite t

Enoblituzumab, previously known as TJ-271 or MGA271, represents the innovative antibody specific to CD33, a marker found predominantly on cancer tissues. The agent functions as the bispecific therapy, at once attaching to CD33 on cancerous entities and to a CD3 molecule, an component of the T-cel

Apoptosis, also recognized as programmed cell death, plays a vital role in maintaining cellular homeostasis. Dysregulation of apoptosis has been implicated in various pathologies, including cancer, neurodegenerative diseases, and autoimmune disorders. Therefore, modulating apoptotic pathways repr